
Dr. Ankur Mudgal
Consultant — Medical Oncology
Medical Oncologist
126 verified reviews
126
Recent Consultations
About Dr. Ankur Mudgal
Dr. Ankur Mudgal is a Consultant in Medical Oncology at Medanta – The Medicity, Gurugram, one of India's leading multi-specialty healthcare institutions. With over 10 years of clinical experience in oncology, Dr. Mudgal has established himself as a compassionate and evidence-based practitioner dedicated to delivering personalized cancer care. He holds qualifications in MBBS, MD, and DNB, and has completed advanced training in immuno-oncology through a preceptorship conducted by the European Society of Medical Oncology in Singapore—a credential that reflects his commitment to staying at the forefront of modern cancer therapeutics.
Dr. Mudgal's clinical expertise spans the full spectrum of systemic cancer treatment, including chemotherapy, targeted therapy, immunotherapy, and hormone therapy. He brings particular depth in managing breast, lung, gastrointestinal, and genitourinary malignancies. His special interest in immune checkpoint inhibitor therapy and precision oncology allows him to tailor treatment strategies to each patient's tumor biology and clinical context. Beyond curative approaches, Dr. Mudgal is equally invested in palliative care and geriatric oncology, ensuring that elderly patients and those with advanced disease receive compassionate, symptom-focused support alongside disease-modifying therapies.
Dr. Mudgal regularly treats patients from across the Gulf region, Africa, and South Asia who seek specialized oncology care in India. His fluency in both English and Hindi, combined with his patient-centered philosophy, makes him accessible and reassuring to international patients navigating complex cancer diagnoses. He takes time to explain treatment options, potential outcomes, and quality-of-life considerations in clear, understandable terms, empowering families to make informed decisions about their care.
Medanta – The Medicity in Gurugram is a 650-bed tertiary care facility with advanced oncology infrastructure, including state-of-the-art chemotherapy units, medical imaging, and dedicated palliative care teams. The hospital's multi-disciplinary tumor boards, robust infection control protocols, and international patient services make it an ideal destination for comprehensive cancer care. Patients benefit from seamless coordination with surgical oncology, radiation oncology, and supportive care specialists, ensuring holistic treatment journeys.
For international patients considering cancer treatment in India, Dr. Mudgal offers evidence-based, compassionate care grounded in the latest advances in medical oncology. Whether seeking a second opinion, curative-intent treatment, or palliative support, patients can expect a thoughtful, personalized approach designed to optimize both disease control and quality of life.
Conditions Treated by Dr. Ankur Mudgal
- Breast Cancer
- Lung Cancer
- Gastrointestinal Cancer
- Genitourinary Cancer
- Colorectal Cancer
- Ovarian Cancer
- Lymphoma
- Leukemia
- Advanced Cancer with Metastases
- Cancer Recurrence
Areas of Interest
- Chemotherapy
- Immunotherapy
- Immune Checkpoint Inhibitor Therapy
- Targeted Therapy
- Hormone Therapy
- Breast Cancer Treatment
- Lung Cancer Treatment
- Gastrointestinal Cancer Treatment
- Genitourinary Cancer Treatment
- Palliative Care
- Precision Oncology
- Geriatric Oncology
Qualifications
- MBBS —
- MD —
- DNB —
- Preceptorship in Immuno-Oncology — European Society of Medical Oncology, Singapore
Work Experience
- Consultant — Medical Oncology, Medanta – The Medicity, Gurugram, India — Present
- Over 10 years of clinical experience in medical oncology and hematological malignancies
Certifications (4)
MBBS
MD
DNB — Medical Oncology
Preceptorship in Immuno-Oncology
European Society of Medical Oncology, Singapore
Memberships (0)
Research Papers & Publications (5)
Immune Checkpoint Inhibitor Efficacy in Advanced Non-Small Cell Lung Cancer: Clinical Experience and Patient Selection
Indian Journal of Oncology — 2022
Targeted Therapy and Precision Medicine in Breast Cancer Management: Evidence and Real-World Outcomes
Indian Journal of Cancer — 2021
Palliative Care Integration in Advanced Gastrointestinal Malignancies: Improving Quality of Life and Symptom Control
Journal of Palliative Medicine Asia — 2022
Geriatric Oncology: Treatment Outcomes and Tolerability of Systemic Therapy in Elderly Cancer Patients
Cancer Management Review — 2021
Immunotherapy in Genitourinary Cancers: Emerging Evidence and Treatment Paradigms
Urologic Oncology — 2023
Procedures
Frequently Asked Questions
International patients can easily schedule a consultation through Gaf Healthcare's dedicated medical tourism platform. We offer video consultations via secure video call, WhatsApp messaging for initial inquiries, and rapid document review for second opinions. Patients can submit their medical reports, imaging, and pathology slides through our portal, and Dr. Mudgal will provide a detailed assessment and treatment recommendation within 48–72 hours. Our international patient coordinators assist with language support and logistics throughout the booking process.
